Search Reports :
Press Releases
Search Archive:  

 

Multinationals Identifying Potential of India, Vaccine Market to Grow 20%

Oct 25, 2008
Share |
 
According to “Global Vaccine Market Forecast to 2012”, our new research study, India represents one of the fastest growing vaccine markets in the world, with the market closing at around INR 39 Billion (US$ 900 Million) in 2006-07.
 
Domestic companies presently dominate this market with around seven out of top ten players being domestic companies. But with India’s IPR laws improving considerably and healthcare expenditure increasing, foreign companies have started to acknowledge India’s potential as a vaccine hub.
 
Thus, the presence of multinationals in the country has increased dramatically in the last 2-3 years with companies like Wyeth, GlaxoSmithKline, Sanofi-Aventis and Eli Lilly launching a number of innovative products in the country. And owing to the factors like increasing public and private healthcare spending, birth of around 15 Million babies each year and a large prevalence of both infectious and chronic diseases, the domestic demand for vaccines in India will continue to grow at double-digit growth rate, offering foreign players enough opportunities to expand their horizon in the country.
 
Apart from the domestic market, India is also emerging as a center for exports. Both research and manufacturing of vaccines can be done in India at a fraction of the cost than in the west. Exports presently account for around 65% of the country’s vaccine market and with growing investment by both domestic and international players, India is expected to fulfill the vaccine demand of both developing and developed countries alike.
 
Global Vaccine Market Forecast to 2012” provides market-based research and gives insights into the global vaccine market. It rationally analyzes the market and presents a thorough statistical and analytical overview on the global vaccine market, and gives historical as well as future outlook on the Indian vaccine market. The research extensively details on the opportunities and challenges that are expected to arise within and from the vaccine market to help clients position their strategies accordingly.
 
For more information visit: http://www.rncos.com/Report/IM153.htm

Related Press Releases:
» Influenza Vaccine Market Set for Stupendous Growth by 2012
» India to Emerge as Vaccine Manufacturing Hub
» Influenza to Drive Vaccine Market Above Expectations
» Global Vaccine Market to Post Double Digit Growth
» Vaccine Market to Drive Future Pharmaceutical Growth
 
Related Research Reports
Related Research News
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Dec 30, 2009
Indian Private Hospital Industry to Generate $45 Billion by 2012
Nov 15, 2009
Indian Pharma Market Set to Shine in Global Arena
Oct 21, 2009
Global Pharmaceutical Market to Grow 4%-6% Next Year
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL
Copyright © 2010, RNCOS, 2002-2010
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707